NO993627D0 - Anvendelse av en forbindelse for fremstilling av et legemiddel - Google Patents

Anvendelse av en forbindelse for fremstilling av et legemiddel

Info

Publication number
NO993627D0
NO993627D0 NO993627A NO993627A NO993627D0 NO 993627 D0 NO993627 D0 NO 993627D0 NO 993627 A NO993627 A NO 993627A NO 993627 A NO993627 A NO 993627A NO 993627 D0 NO993627 D0 NO 993627D0
Authority
NO
Norway
Prior art keywords
medicament
manufacture
compound
Prior art date
Application number
NO993627A
Other languages
English (en)
Other versions
NO993627L (no
Inventor
Yasufumi Shirasaki
Hitoshi Yamaguchi
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO993627L publication Critical patent/NO993627L/no
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of NO993627D0 publication Critical patent/NO993627D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
NO993627A 1993-05-25 1999-07-26 Anvendelse av en forbindelse for fremstilling av et legemiddel NO993627D0 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP12293393 1993-05-25

Publications (2)

Publication Number Publication Date
NO993627L NO993627L (no) 1994-11-28
NO993627D0 true NO993627D0 (no) 1999-07-26

Family

ID=14848208

Family Applications (2)

Application Number Title Priority Date Filing Date
NO941915A NO941915L (no) 1993-05-25 1994-05-24 Madikament for nervebeskyttelse
NO993627A NO993627D0 (no) 1993-05-25 1999-07-26 Anvendelse av en forbindelse for fremstilling av et legemiddel

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO941915A NO941915L (no) 1993-05-25 1994-05-24 Madikament for nervebeskyttelse

Country Status (10)

Country Link
US (2) US5661150A (no)
EP (1) EP0627219A1 (no)
CN (1) CN1100301A (no)
AU (2) AU684270B2 (no)
CA (1) CA2124284C (no)
FI (1) FI942400A (no)
NO (2) NO941915L (no)
PH (1) PH31213A (no)
RU (1) RU2135162C1 (no)
TW (1) TW309427B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100372188B1 (ko) * 1994-11-14 2003-05-12 다이이찌 세이야꾸 가부시기가이샤 3-[2-[4-(3-클로로-2-메틸페닐)-1-피레라지닐]에틸]-5,6-디메톡시-1-(4-이미다졸릴메틸)-1h-인다졸이염산염의결정및이의제조방법
CA2188816C (en) * 1996-04-23 2009-09-22 Takeda Chemical Industries, Ltd. Composition containing .alpha.-fodrin or .alpha.- fodrin fragment protein
US7202279B1 (en) 1998-02-11 2007-04-10 Georgetown University Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders
DE19820224A1 (de) * 1998-05-06 1999-12-09 Markus Schott Bindungspartner und Verfahren zur kompetitiven Hemmung der Bindung zwischen NEF-Protein und Calmodulin, sowie Mittel und Verwendung bei HIV-Erkrankungen
ES2246575T3 (es) * 1998-06-17 2006-02-16 Bristol-Myers Squibb Company Prevencion del infarto cerebral mediante la administracion de una combinacion de un farmaco antiplaquetario bloqueador del receptor adp y un farmaco antihipertensivo.
US6105582A (en) * 1998-07-28 2000-08-22 Pranevicius; Osvaldas Cerebral blood outflow maintenance during intracranial hypertension
US6803233B2 (en) * 2000-07-31 2004-10-12 The Regents Of The University Of California Model for Alzheimer's disease and other neurodegenerative diseases
GB2377635B (en) 2001-04-17 2005-10-19 Hoffmann La Roche Novel use of neuronal calcium sensor-1 (NCS-1) in therapy of CNS disorders and in the development of therapeutic agents
WO2007062862A2 (en) * 2005-12-02 2007-06-07 Ludwig Maximilians Universität München Use of calmodulin inhibitors for the treatment of neurodegenerative disorders
WO2024018245A1 (en) 2022-07-22 2024-01-25 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of calpain inhibitors for the treatment of the diabetic kidney disease

Also Published As

Publication number Publication date
CA2124284C (en) 2002-10-01
EP0627219A1 (en) 1994-12-07
RU94017849A (ru) 1997-05-27
CA2124284A1 (en) 1994-11-26
PH31213A (en) 1998-05-05
NO993627L (no) 1994-11-28
AU5837298A (en) 1998-05-21
FI942400A0 (fi) 1994-05-24
RU2135162C1 (ru) 1999-08-27
AU6333194A (en) 1994-12-01
NO941915D0 (no) 1994-05-24
US5837706A (en) 1998-11-17
AU684270B2 (en) 1997-12-11
TW309427B (no) 1997-07-01
FI942400A (fi) 1994-11-26
CN1100301A (zh) 1995-03-22
US5661150A (en) 1997-08-26
NO941915L (no) 1994-11-28

Similar Documents

Publication Publication Date Title
NO306235B1 (no) Anvendelse av et legemiddel for behandling av artritt
NO921777D0 (no) Fremgangsmaate for fremstilling av isoparaffiner
NO20040145L (no) Anvendelse av benzensulfonamidderivater for fremstilling av et medikament
NO179941C (no) Farmasöytisk forbindelse
FI944885A (fi) Tölkin perusosa
NO931346L (no) Fremgangsmaate for fremstilling av et bifenylderivat
FI945085A0 (fi) Yhdistelmä-neu-reseptoristimulaatiotekijä
FI915242A (fi) Rf-skaermning av kretskort
FI954007A (fi) Substituoitujen 4-fenyyli-6-amino-nikotiinihappojohdannaisten käyttö lääkeaineena
NO920508D0 (no) Fremgangsmaate for fremstilling av et polyolefinskum
FI934749A (fi) Foerfarande foer framstaellning av aromatiska brommetylfoereningar
FI931234A0 (fi) Foerfarande foer oevervakning av en patients tillstaond
NO923765L (no) Et trinns fremgangsmaate for fremstilling av dirithromycin
DE69328228T2 (de) Wundheilmittel
NO934145L (no) Farmasöytiske forbindelser
NO993627D0 (no) Anvendelse av en forbindelse for fremstilling av et legemiddel
NO932515D0 (no) Fremgangsmaate ved fremstilling av voerter
EE03384B1 (et) Melatoniini kasutamine ravimi tootmiseks
NO950714D0 (no) Anvendelse av en tricyklisk forbindelse for fremstilling av medisinske preparater
LV12067A (lv) 17B-N-vienaizvietota-karbamoil-4-aza-5alfa-androst-1-en-3-onu pielietojums medikamenta razosanai
IS4310A (is) Nýtt læknisfræðilega virkt efnasamband
NO921538L (no) Fremgangsmaate for fremstilling av et glycidylazid-polymerazid
NO930519D0 (no) Fremgangsmaate for fremstilling av mikrokuleholdige termostivende harpiksmaterialer
NO923288D0 (no) Fremgangsmaate for fremstilling av pressformede materialer
NO921607D0 (no) Fremgangsmaate for fremstilling av vannloeselig fosfatert guar